1. Introduction {#j_med-2016-0052_s_001}
===============

Multiple sclerosis (MS) is a kind of demyelinating disease in which the insulating cover of nerve cells in the brain and spinal cord are damaged. And it was reported that MS is the most common diagnosized autoimmune disease which can affect the central nervous system. Clinical epidemology study estimated that about 2,300,000 subjects were affected by MS globally in the year of 2013, and about 20,000 people died from MS at the same year \[[@j_med-2016-0052_ref_001]\]. MS has the ability to reduce the communication of the central nervous system, which can lead to a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems \[[@j_med-2016-0052_ref_002]\]. Generally, MS is not believed to be a hereditary disease, but some studies indicated that the genetic variations could have an association with the increasing risk of developing MS \[[@j_med-2016-0052_ref_003]\]. One of the related genes is cytotoxic T lymphocyte-associated antigen 4(CTLA-4), which is expressed on the surface of T cells and is critical in inhibiting T cell activation. Several studies have reported a significant correlation between CTLA-4 gene rs221775A\>G single nucleotide polymorphism and multiple sclerosis susceptibility \[[@j_med-2016-0052_ref_004], [@j_med-2016-0052_ref_005]\]. However, other studies have not find a significant correlation \[[@j_med-2016-0052_ref_006]-[@j_med-2016-0052_ref_008]\]. Thus, we performed a meta-analysis by pooling all the available data related to CTLA-4 gene rs221775A\>G single nucleotide polymorphism and multiple sclerosis susceptibility in order to further evaluted the corrlation.

2. Method {#j_med-2016-0052_s_002}
=========

2.1. Publication search strategy {#j_med-2016-0052_s_002_s_001}
--------------------------------

The open published studies about the CTLA-4 gene rs221775A\>G single nucleotide polymorphism and multiple sclerosis susceptibility were searched in the databases of Pubmed Embase and China National Knowledge Infrastructure (CNKI). The case-control or cohort studies published in English or Chinese were all searched in the databases before Jan 2016. The search strategy and text words were: "cytotoxic T lymphocyte associated antigen/CTLA-4/CTLA4", "multiple sclerosis/MS" or "polymorphism". The references for the included papers were also screened to identify additional potential suitable studies which were not indexed in the pubmed or CNKI databases.

2.2. Inclusion and exclusion criteria {#j_med-2016-0052_s_002_s_002}
-------------------------------------

The inclusion criteria were as follows: (1) the study design was cases-cotrol or cohort; (2) the paper was published in English or Chinese; (3) the genotyping method is correct; (4) the frequency of AA, AG and GG nucleotide can be extracted from the original study. And the exclusion criteria were: (1) the study design type were review or case report; (2) studies with duplicate published datas; (3) Studies publised in other languages (not English or Chinese); (4) the data extracted from the original studies was not enough to calculate the ORs.

2.3. Data evaluation {#j_med-2016-0052_s_002_s_003}
--------------------

Two reviewers (XIAO Haibing & CAO Xu) of this manuscript independently reviewed the papers and extracted the data according to the Cochrane Handbook. The general information such as first author, the paper publication year, the country of the study performed, and the race of the included subjects for each of the included paper were extacted. The frequency of AA, AG and GG nucleotide for the include 20 studies were canrefully extracted and corss checked, which was used to calculated the pooled ORs. If disagreements were encountered, the discussion was made and a third reviewer was consulted.

2.4. Statistical analysis {#j_med-2016-0052_s_002_s_004}
-------------------------

Stata/SE 11.0（StataCorp LP, <http://www.stata.com> were used for statistical analysis. The correlation between CTLA-4 gene rs221775A\>G single nucleotide polymorphism and multiple sclerosis susceptibility was demonstrated by odds ratio (OR) and its 95% confidence interval (95%CI). Statistical heterogeneity among studies was evaluated by I2 \[[@j_med-2016-0052_ref_009]\]. If significant heterogeneity was found (I^2^＞50%), the random-effect method (Dersimonian-Laird method) was used to pool the data. Inversely, fixed-effect method was applied. The publication bias was detected by Begg's funnelplot.

3. Results {#j_med-2016-0052_s_003}
==========

3.1. General information of the included studies {#j_med-2016-0052_s_003_s_001}
------------------------------------------------

Through searching the databases, 86 related publication were initial identified. 66 studies were excluded after reviewing the complete text. Overall, we included twenty published articles in this meta-analysis with 5025 MS patients and 4706 controls. For the inlcuded 20 open published studies, 14 articles included the subjects with race of Caucasus, 3 with Arab, 1 with mixed, 1 with Asian and 1 with Australoid. The publication year ranged form 1999 to 2011. All papers were published in English. General information of the included 20 papers are demonstrated in [Table 1](#j_med-2016-0052_tab_001){ref-type="table"}.

###### 

General information for the included studies

  Authors                                            Year   Country       Race         No    Case   Control                          
  -------------------------------------------------- ------ ------------- ------------ ----- ------ --------- ----- ---- ----- ----- ----
  Ligers etal\[[@j_med-2016-0052_ref_004]\]          1999   Sweden        Caucasus     378   237    117       188   73   83    123   31
  Rasmussen(1) et al\[[@j_med-2016-0052_ref_006]\]   2001   Denmark       Caucasus     84    125    28        39    17   35    68    22
  Rasmussen(2) et al\[[@j_med-2016-0052_ref_006]\]   2001   Denmark       Caucasus     42    86     4         23    15   7     34    45
  Andreevskii et al\[[@j_med-2016-0052_ref_007]\]    2002   Russia        Caucasus     168   209    51        85    32   68    104   37
  Masterman et al\[[@j_med-2016-0052_ref_008]\]      2002   Sweden        Caucasus     374   290    120       188   66   82    139   69
  Maurer et al\[[@j_med-2016-0052_ref_005]\]         2002   Germany       Caucasus     330   152    132       157   41   66    69    17
  Bocko et al\[[@j_med-2016-0052_ref_010]\]          2003   Poland        Caucasus     102   101    31        57    14   35    53    13
  Kantarci et al\[[@j_med-2016-0052_ref_011]\]       2003   USA           Mixed        120   235    45        59    15   89    111   35
  van Veen et al\[[@j_med-2016-0052_ref_012]\]       2003   Netherlands   Caucasus     514   181    215       229   70   72    85    24
  Bilinska et al\[[@j_med-2016-0052_ref_013]\]       2004   Poland        Caucasus     152   154    47        80    25   50    84    20
  Teutsch et al\[[@j_med-2016-0052_ref_014]\]        2004   Australia     Caucasus     102   152    30        54    18   64    61    27
  Fukazawa et al\[[@j_med-2016-0052_ref_015]\]       2005   Japan         Asian        133   156    23        69    41   29    66    61
  Lorentzen et al\[[@j_med-2016-0052_ref_016]\]      2005   Norway        Caucasus     513   509    164       251   98   168   249   92
  Malferrari etal \[[@j_med-2016-0052_ref_017]\]     2005   Italy         Caucasus     95    104    40        46    9    37    54    13
  Dincic et al\[[@j_med-2016-0052_ref_018]\]         2006   Montenegro    Caucasus     162   102    96        56    10   41    52    9
  Heggarty et eal\[[@j_med-2016-0052_ref_019]\]      2007   England       Caucasus     330   158    129       148   53   46    84    28
  Greve(1) etal \[[@j_med-2016-0052_ref_020]\]       2008   Poland        Caucasus     180   171    59        96    25   49    90    32
  Greve(2) etal\[[@j_med-2016-0052_ref_020]\]        2008   Germany       Caucasus     200   464    75        90    35   178   216   70
  Greve(3) etal\[[@j_med-2016-0052_ref_020]\]        2008   Hungary       Caucasus     193   91     64        96    33   32    48    11
  Wray et al\[[@j_med-2016-0052_ref_021]\]           2008   Australia     Australoid   198   224    65        111   22   86    107   31
  Yousefipour et al \[[@j_med-2016-0052_ref_001]\]   2009   Iran          Arab         153   190    79        56    18   117   59    14
  Heidari et al\[[@j_med-2016-0052_ref_022]\]        2010   Iran          Arab         135   135    42        69    24   38    74    23
  Cizmarevic et al\[[@j_med-2016-0052_ref_023]\]     2011   Iran          Arab         367   480    151       165   51   198   221   61

3.2. Dominant genetic model (GG+AG vs AA) {#j_med-2016-0052_s_003_s_002}
-----------------------------------------

For the dominant genetic model (GG+AG vs AA), significant heterogeneity across the included twenty article existed (I^2^=82.5%, *P*=0.00). The OR was pooled by random effect model. The pooled OR was 1.06 and 95% confidence interval was 0.86～1.30 wich indicated that there was no significant association between CTLA-4 gene rs221775 A\>G single nucleotide polymorphism and multiple sclerosis susceptibility in dominant genetic model (GG+AG vs AA ([Figure 1](#j_med-2016-0052_fig_001){ref-type="fig"}). The begg's funnel plot indicated no significant publication bias ([Figure 2](#j_med-2016-0052_fig_002){ref-type="fig"}).

![The forest plot of OR for CTLA-4 gene rs221775 A\>G single nucleotide polymorphism and multiple sclerosis susceptibility under dominant model (GG+AG vs AA).](j_med-2016-0052_fig_001){#j_med-2016-0052_fig_001}

![The Begg's funnel plots showe no significant publication bias under dominant model (GG+AG vs AA)](j_med-2016-0052_fig_002){#j_med-2016-0052_fig_002}

3.3. Homozygous genetic model (GG vs AA) {#j_med-2016-0052_s_003_s_003}
----------------------------------------

For the homozygous genetic model (GG vs AA), no significant heterogeneity across the included 20 articles were found (I^2^=0.80%, *P*=0.45). So, the OR was pooled by fixed effect model. The pooled OR showed no significant correlation between CTLA-4 gene rs221775 A\>G single nucleotide polymorphism and multiple sclerosis susceptibility was found in homozygous genetic model (GG vs AA) ([Figure 3](#j_med-2016-0052_fig_003){ref-type="fig"}). The pulication bias was evaluated by funnel plot, which indicated no significant publication bias ([Figure 4](#j_med-2016-0052_fig_004){ref-type="fig"}).

![The forest plot of OR for CTLA-4 gene rs221775 A\>G single nucleotide polymorphism and multiple sclerosis susceptibility under homozygous genetic model (GG vs AA).](j_med-2016-0052_fig_003){#j_med-2016-0052_fig_003}

![The Begg's funnel plots showe no significant publication bias homozygous genetic model (GG vs AA).](j_med-2016-0052_fig_004){#j_med-2016-0052_fig_004}

3.4. Recessive genetic model (GG vs AG+AA) {#j_med-2016-0052_s_003_s_004}
------------------------------------------

For the recessive genetic model (GG vs AG+AA), the heterogeneity across the studies were assesed by I2 which showed no significant heterogeneity across the studies (I^2§^=81.2%, *P*=0.45). We pooled the data by fixed effect mode. The pooled the results indicated no statistical association between CTLA-4 gene rs221775 A\>G single nucleotide polymorphism and multiple sclerosis susceptibility in recessive genetic model (GG vs AG+AA) ([Figure 5](#j_med-2016-0052_fig_005){ref-type="fig"}). And begg's funnel plot was symmetric which indicated no significant publication bias ([Figure 6](#j_med-2016-0052_fig_006){ref-type="fig"}).

![The forest plot of OR for CTLA-4 gene rs221775 A\>G single nucleotide polymorphism and multiple sclerosis susceptibility under recessive genetic model (GG vs AG+AA)](j_med-2016-0052_fig_005){#j_med-2016-0052_fig_005}

![The Begg's funnel plots showe no significant publication bias under recessive genetic model(GG vs AG+AA)](j_med-2016-0052_fig_006){#j_med-2016-0052_fig_006}

4. Discussion {#j_med-2016-0052_s_004}
=============

Generally, the causes for MS is unclear. However, it is believed that it could be the result of a combination of genetic and environmental factorial influences (such as infectious agents) \[[@j_med-2016-0052_ref_024]\]. Results of publised studies have demonstrated that some genetic variations can increase the risk of developing MS \[[@j_med-2016-0052_ref_011]\]. These genes seem to be expresed higher in microglial cells than expected by chance. Cytotoxic T-lymphocyte-associated protein 4 gene was one of these genes that was positive expressed in activated T lymph cells and played an important role in inhibiting the function of T lymph cell \[[@j_med-2016-0052_ref_025]\].

CTLA-4, also known as CD152 (cluster of differentiation 152), is a protein receptor that functions as an immune checkpoint, downregulates the immune system. Animal experiment showed that disruption of CTLA-4 leads to fatal lymphoproliferative disorder, which could result in a widespread autoimmunity in mice \[[@j_med-2016-0052_ref_026]\]. Recently, seveal studies have found the cytotoxic T-lymphocyte-associated protein 4(CTLA-4) gene rs221775A\>G single nucleotide polymorphism to be associated with the susceptibility of multiple sclerosis \[[@j_med-2016-0052_ref_004], [@j_med-2016-0052_ref_019]\]. Heggarty and his colleges \[[@j_med-2016-0052_ref_019]\] discussed the relationship between CTLA4 gene polymorphisms and multiple sclerosis risk in Northern Ireland. They found that people with A allele and AA genotype of rs221775 had more risk of developing MS (OR=1.36, P\<0.05 for A allele and OR=1.81, P\<0.05 for AA genotype).

Significnat correlation between CTLA-4 gene rs221775A\>G single nucleotide polymorphism and MS risk was demonstrated in their study. Kantarci et al \[[@j_med-2016-0052_ref_011]\] also found that CTLA4 was associated with susceptibility to multiple sclerosis. They performed a population-based sample of 122 sporadic patients with MS and 244 age-, gender- and ethnicity-matched controls, and by linkage and family-based association methods in 395 individuals from 59 American multiplex pedigrees with 141 affected individuals. They found a strong association with age at onset, disease course and severity. Moreover they found that CTLA-4 was associated with the susceptibility to MS.

On the other hand, Greve et al \[[@j_med-2016-0052_ref_020]\] found no association between CTLA4 polymorphism and MS susceptibility in patients from Germany, Hungary and Poland. Thus, the results for CTLA4 polymorphism and MS risk is not conclusive within published articles. The current meta-analysis pooling of publised data were preformed in order to further evaluated the correlation between CTLA4 gene polymorphisms and multiple sclerosis. We included 20 studies involving 5025 MS patients and 4706 controls. No significant correlation between CTLA4 polymorphism and MS in dominant genetic model (GG+AG vs AA), homozygous genetic model (GG vs AA) or recessive genetic model(GG vs AG+AA) genetic model were found.

There are several limitations with the present meta-analysis to be considered. Firstly, heterogeneity existed in dominant genetic model (GG+AG vs AA), which could reduce the statistical power for pooling the data. Secondly, only paper published in English or Chinese had been screened in the databases and include. Thirdly, MS is a complex diseases, which is the result of the combined actions of multiple susceptibility genes and one or more environmental factors, and only the association between one single nucleotide polymorphism for one gene was evaluated which may not be enough.
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